WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.01 Cr | ₹-15 Cr | ₹-44 Cr | ₹130 Cr | ₹0.78 Cr |
What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1.01 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹-44 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹0.78 Cr |
How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.01 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹-44 Cr | Negative | |
| Mar2022 | ₹130 Cr | 16,663.92 | |
| Mar2021 | ₹0.78 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,663.5 Cr | -0.4% | -7.2% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.4% |
-7.2% |
-6.7% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses